The Biggest Week in Psychedelic Medicine Isn’t About Psychedelics. It’s About What Comes Next.
Clinical Insight · Provider Education The Biggest Week in Psychedelic Medicine Isn’t About Psychedelics. It’s About What Comes Next. By Shelley Junkin, COO · July 2026 · 10 min read If it feels like we have been saying, “This is a historic moment for psychedelic medicine,” you are not wrong. But this time, it truly […]
The Future of Functional Medicine Is Being Discussed in Real Time—Are Providers Paying Attention?
Clinical Insight · Provider Education The Future of Functional Medicine Is Being Discussed in Real Time — Are Providers Paying Attention? By Shelley Junkin, COO · May 2026 · 8 min read The future of functional medicine and mental health care is rapidly evolving, and providers are beginning to recognize a major shift occurring in […]
From Optimization to Protection: What Providers Should Know About Brain Health and Cognitive Decline
Brain Health · Cognitive Wellness From Optimization to Protection: What Providers Should Know About Brain Health and Cognitive Decline By Shelley Junkin, COO · April 2026 · 9 min read In recognition of Alzheimer’s and Brain Awareness Month, the conversation around brain health often shifts toward diagnosis and disease. But for many providers, the more […]
The Hidden Risks of “Research Use Only” (RUO) Peptides: What Providers Need to Know
Provider Compliance · Peptide Therapy The Hidden Risks of “Research Use Only” Peptides: What Providers Need to Know By Shelley Junkin, COO · April 2026 · 10 min read As regulatory restrictions around certain peptides have increased, patient demand has not disappeared. In many cases, it has simply shifted toward less transparent and potentially higher-risk […]
From Burnout to Balance: Why Providers Are Turning to Functional Medicine
Provider Wellness · Functional Medicine From Burnout to Balance: Why Providers Are Turning to Functional Medicine By Shelley Junkin, COO · June 2026 · 9 min read The Shift No One Is Talking About—But Everyone Is Feeling Across healthcare, something is changing—and providers are feeling it every day. Not because they have stopped caring, but […]
The Overlooked Revenue Opportunity Sitting in Plain Sight: B12 Injections
Practice Growth · Injectable Wellness The Overlooked Revenue Opportunity Sitting in Plain Sight: B12 Injections By Shelley Junkin, COO · April 2026 · 7 min read In functional and integrative medicine, providers are constantly looking for solutions that help patients feel better while fitting naturally into a sustainable and efficient practice model. The most valuable […]
Beyond Brain Fog: How Neuropeptides Are Reshaping Brain Health in Clinical Practice
Clinical Insight · Peptide Therapy Beyond Brain Fog: How Neuropeptides Are Reshaping Brain Health in Clinical Practice By Shelley Junkin, COO · May 2026 · 9 min read Across clinical practices, providers are seeing a clear shift in patient demand—less focus on reactive care and a growing expectation for support in optimizing how patients think, […]
The Problem Isn’t the Patient—It’s the Reference Range
Clinical Insight · Hormone Optimization The Problem Isn’t the Patient—It’s the Reference Range By Shelley Junkin, COO · March 2026 · 9 min read “Your labs are normal.” There may be no phrase more clinically accurate—and more incomplete—than that statement. Because in today’s care model, “normal” often means one thing: the patient isn’t sick enough […]
Beyond the Refill: Why Patient Follow-Up May Be Your Practice’s Most Overlooked Growth Strategy
Practice Growth · Patient Retention Beyond the Refill: Why Patient Follow-Up May Be Your Practice’s Most Overlooked Growth Strategy By Shelley Junkin, COO · June 2026 · 9 min read Most practices spend significant time and money attracting new patients. Marketing campaigns. Social media. Community outreach. Referral programs. Yet one of the greatest opportunities for […]
Emerging Research: Ivermectin, Metabolism, and the Cellular Environment
Emerging Research · Cellular Health Emerging Research: Ivermectin, Metabolism, and the Cellular Environment By Shelley Junkin, COO · March 2026 · 7 min read Ivermectin, a medication widely used for decades to treat parasitic infections, has recently drawn attention in oncological research. Scientists are investigating whether this well-known drug may influence cellular pathways involved in […]